SAICNasdaqServices-Computer Integrated Systems DesignFiscal year ends January 29
Science Applications International Corp
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Aug 31, 2026
$133.13+0.06 (+0.05%)
Close on Oct 19, 2026
- Market cap
- $5.70B
- P/E (TTM)
- 17.3
- Dividend yield
- 1.11%
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
12.0%+0.8 pts over 5 years
Operating margin
7.2%+1.6 pts over 5 years
Net margin
–
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -2.9% | -2.0% | +0.6% | +5.3% | |
| Gross profit | -2.2% | -0.6% | +1.9% | +7.8% | |
| Operating income | -7.5% | +1.3% | +6.0% | +8.7% | |
| EPS, diluted | +7.4% | +12.7% | +16.7% | +12.0% | |
| Free cash flow | +26.0% | +4.4% | -4.0% | +10.8% | |
| Dividend per share | 0.0% | 0.0% | 0.0% | +2.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | 39.2% | 14.1% | – | |
| Return on assets | 6.9% | 4.0% | – | |
| Current ratio | 1.45 | 1.01 | 1.20 | |
| Debt to equity | 3.00 | 1.63 | 1.66 | |
| Net debt to EBITDA | 2.90× | 5.51× | 4.18× | |
| Interest coverage | 5.1× | 3.2× | – | |
| Inventory turnover | 57.6× | 77.3× | – | |
| Capex to revenue | 0.3% | 0.7% | 0.4% | |
| Diluted shares | 46M | 59M | 47M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Science Applications International generated $2.55B from operations and spent $2.43B on capital expenditure, dividends and share buybacks. 6% of that went back into the business.
Generated
$2.55B
Used
$2.43B
Capital expenditure$156.00M6%Dividends$393.00M16%Share buybacks$1.88B77%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin4.8%
×Asset turnover1.42×
×Equity multiplier3.14×
=Return on equity, FY202521.5%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 4.8% | 1.42× | 3.14× | 21.5% |
| FY2024 | 6.4% | 1.37× | 3.12× | 27.4% |
| FY2023 | 3.9% | 1.36× | 3.41× | 18.1% |
| FY2022 | 3.7% | 1.29× | 3.63× | 17.5% |
| FY2021 | 3.0% | 1.35× | 3.53× | 14.1% |
| FY2020 | 3.5% | 1.38× | 3.20× | 15.6% |
| FY2019 | 2.9% | 1.40× | 3.66× | 15.1% |
| FY2018 | 4.0% | 2.16× | 6.09× | 53.0% |
| FY2017 | 3.2% | 2.13× | 5.71× | 39.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
4of 6 tests passed in fiscal 2026. Some tests lack the figures they need.
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$609.00M
- Return on assets improvedROA up on the prior year6.8% → –
- Earnings backed by cashOperating cash flow above net income$609.00M vs –
- Less leverageLong-term debt to assets fell36.4% → 46.1%
- Better liquidityCurrent ratio rose0.83 → 1.20
- No dilutionShare count did not rise51M → 47M
- Gross margin improvedGross margin up on the prior year11.93% → 12.01%
- More efficientAsset turnover rose1.41 → 1.38